Amanote Research
Register
Sign In
Consolidation Radiotherapy Does Not Improve the Outcome as Compared With Chemotherapy Alone in Patients With Limited Stage Diffuse Large B-Cell Lymphoma of Waldeyer's Ring
Hematological Oncology
- United Kingdom
doi 10.1002/hon.2439_76
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2017
Authors
C. Li
X. Ma
Z. Pan
F. Lv
Z. Xia
K. Xue
Q. Zhang
D. Ji
J. Cao
X. Hong
Y. Guo
Publisher
Wiley
Related search
Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma With Post-Chemotherapy Complete Remission
PLoS ONE
Multidisciplinary
Stage Ia Non-Hodgkin's Lymphoma of the Waldeyer's Ring Limited Chemotherapy and Radiation Therapy Versus Radiation Therapy Alone
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Rituximab, Lenalidomide, and Ibrutinib Alone and Combined With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcome After Salvage Radiotherapy to FDG-Pet/Ct Avid Disease Post Chemotherapy in Advanced Stage Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Non-Anthracycline Chemotherapy Associated With a Poor Outcome in Elderly Egyptian Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
Journal of Cancer Metastasis and Treatment
Population Pharmacokinetics of Rituximab in Patients With Diffuse Large B-Cell Lymphoma and Association With Clinical Outcome
British Journal of Clinical Pharmacology
Pharmacology
Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone Prior to Combination With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
High-Risk Patients With Diffuse Large B-Cell Lymphoma Are Not Enrolled on Clinical Trials
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology